Feasibility of Meal Delivery Postpartum

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05579990
Collaborator
(none)
20
1
1
18
1.1

Study Details

Study Description

Brief Summary

This study is being done to assess the feasibility and acceptability of a meal delivery intervention among low-income postpartum women with obesity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Meal Delivery
N/A

Detailed Description

This is a single-group pilot study in which subjects will receive 10 home-delivered meals per week for 8 weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Masking Description:
All participants enrolled in the study will receive the meal delivery intervention, so blinding is not possible.
Primary Purpose:
Other
Official Title:
Feasibility of a Meal Delivery Intervention for Postpartum Weight Management
Anticipated Study Start Date :
Jan 31, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Meal Delivery

Meal delivery intervention program designed to help low income postpartum women lose weight through weekly meal delivery and behavioral strategies.

Behavioral: Meal Delivery
10 home-delivered meals per week provided by a local meal delivery company supplemented by remote weekly behavioral support with study staff.

Outcome Measures

Primary Outcome Measures

  1. Participant Adherence to Intervention [Collected weekly from intervention start (6-21 weeks postpartum) to follow-up (14-29 weeks postpartum)]

    Proportion of weekly study meals participants consumed based on responses to weekly electronic surveys in which participants will report the number of study meals a) they consumed, b) other household members consumed, or c) that were uneaten.

Secondary Outcome Measures

  1. Study Participation Rate [baseline (5-19 weeks postpartum)]

    Percentage of eligible subjects who agreed to participate out of those who were screened

  2. Participant Retention [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    The proportion of enrolled participants who complete follow-up

  3. Change in Participant Satisfaction with Diet [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses are average to produce a total diet satisfaction score ranging from 1-5. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning & Preparation Factor will be examined from baseline to follow-up.

Other Outcome Measures

  1. Change in Weight [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    Body weight measured at baseline and follow-up will be used to calculate weight change.

  2. Change in Food Security [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security.

  3. Change in Perceived Stress [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    Determined using the 10-item Perceived Stress Scale (PSS-10) based on the last month. PSS-10 scores range from 0 to 40, with higher scores representing higher levels of perceived stress.

  4. Change in Healthy Eating Self-Efficacy [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    Participants will be asked to score 3 statements on a 5-point Likert scale ranging from 1=very sure to 5=very unsure (adapted from Lipsky LM et al. 2016). Responses are reverse coded and averaged, so higher scores reflect increasing self-efficacy.

  5. Change in Weight Control Self-Efficacy [baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)]

    Participants will be asked to score 3 statements on a 5-point Likert scale ranging from 1=very sure to 5=very unsure (adapted from Lipsky LM et al. 2016). Responses are reverse coded and averaged, so higher scores reflect increasing self-efficacy.

  6. Change in Healthy Eating Index score from baseline to follow-up [three 24-hour dietary recalls on non-consecutive days at baseline (5-19 weeks postpartum) and follow-up (14-29 weeks postpartum)]

    Determined based on the Healthy Index Score, in which 100 indicates complete alignment with the Dietary Guidelines for Americans and 0 is the minimum score, as calculated from three 24-hour dietary recalls conducted on non-consecutive days (2 weekdays + 1 weekend day) at each time point.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Medicaid eligible and/or have a household income at or below 185 percent of the federal poverty line

  • 18 years of age or older

  • Initiated prenatal care at a University of Alabama at Birmingham prenatal clinic

  • Experienced a healthy singleton pregnancy

  • 5-18 weeks postpartum at enrollment

  • Body mass index >= 30 at enrollment

  • Residing within the meal company's delivery radius

  • Willing to consent

Exclusion Criteria:
  • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)

  • Current treatment for severe psychiatric disorder (such as schizophrenia)

  • Self-reported diagnosis of anorexia or bulimia

  • Current use of medication expected to significantly impact body weight

  • Current substance abuse

  • Participation in another dietary and/or weight management intervention postpartum

  • Unable to understand and communicate in English

  • Unwilling or unable to consume study meals

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

  • Principal Investigator: Camille S Worthington, PhD, University of Alabama at Birmingham

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Camille S Worthington, PhD, Primary Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT05579990
Other Study ID Numbers:
  • IRB-300010155
First Posted:
Oct 14, 2022
Last Update Posted:
Oct 14, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Camille S Worthington, PhD, Primary Investigator, University of Alabama at Birmingham
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2022